The global next generation sequencing market is set to witness a growth rate of ~15% in the next 5 years. Rising demand for ...

Life sciences company Element Biosciences sued Illumina on Monday in separate cases in federal courts in California and ...

The companion diagnostic was once a niche sidekick in oncology, a modest tool for identifying the right patients for a small ...

Next-generation sequencing enhances a biologics manufacturer's ability to detect and identify unknown or unexpected contaminants.

The company says a single node is capable of processing approximately 22,000 genomes annually, triple the amount of earlier releases.

"Illumina has inflicted substantial harm on Element, resulting in lost sales, diminished market share, and reduced profits," counsel for DNA-sequencing company Element Biosciences Inc. alleged in an ...

The global Ligase Enzymes Market, valued at US$0.25 billion in 2024, stood at US$0.26 billion in 2025 and is projected to advance at a resilient ...

Modern agriculture faces mounting challenges from climate change, soil degradation, and rising biotic and abiotic stresses, ...

Alex Zhavoronkov, founder and CEO of Insilico Medicine, explores how A.I. is driving drug discovery breakthroughs—and ...

According to Kadam, scientific and technological advancements in genomics over the past decade have driven affordability and ...

“GOAST v4.0 breaks bioinformatics bottlenecks by combining Lenovo’s HPC expertise with genomics innovation,” said Sumir Bhatia, President, Lenovo ISG Asia Pacific. “With this leap in performance and ...